Cancer Research Targets  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cassoni, P.
Right arrow Articles by Bussolati, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cassoni, P.
Right arrow Articles by Bussolati, G.
[Cancer Research 62, 2406-2413, April 15, 2002]
© 2002 American Association for Cancer Research


Tumor Biology

Oxytocin Is a Growth Factor for Kaposi’s Sarcoma Cells

Evidence of Endocrine-Immunological Cross-Talk1

Paola Cassoni, Anna Sapino, Silvia Deaglio, Benedetta Bussolati, Marco Volante, Luca Munaron, Adriana Albini, Antonietta Torrisi and Gianni Bussolati2

Department of Biomedical Sciences and Human Oncology [P. C., A. S., M. V., G. B.]; Laboratory of Cell Biology, Department of Genetics [S. D.]; Department of Internal Medicine [B. B.]; and Department of Animal and Human Biology and National Institute for the Physics of Matter [L. M.], University of Torino, 10126 Turin; Laboratory of Molecular Biology, Istituto Nazionale per la Ricerca sul Cancro, 16100 Genoa, [A. A.]; and Department of Pathology, University of Catania, 95100 Catania [A. T.], Italy

Oxytocin receptors (OTRs) are expressed in numerous tissues, including human normal endothelium. Here we investigated the expression and biological significance of OTRs in Kaposi’s sarcoma (KS), an intensely angioproliferative disease of possible vascular origin with a prominent inflammatory component. Immunohistochemistry and in situ hybridization studies showed OTR expression in tumor cells of cutaneous classic and AIDS-related KS lesions. OTR mRNA and protein were also detected on cultured KS-IMM spindle cells by reverse transcription-PCR and immunofluorescence procedures. In these cells, OTR expression was up-regulated by the supernatants of resting CD4+ and CD8+ lymphocytes through a still unidentified factor. Functionality of OTRs was demonstrated because OT treatment of KS-IMM cells led to a significant increase in cell proliferation, coupled to the increase of intracellular calcium, but did not effect cell migration in vitro or angiogenesis in vivo. In addition, we demonstrated that CD4+ and CD8+ cells produce OT themselves, thus constituting an intralesional source of peptide. These results indicate that: (a) functioning OTRs are expressed in KS cells and modulated by the inflammatory counterpart of KS lesions; (b) via OTRs, OT stimulates KS-IMM cell proliferation and could, therefore, be considered a new possible relevant growth factor involved in KS progression; and finally (c) the evidence of OT synthesis by CD4+ and CD8+ lymphocytes strongly suggests the existence of local endocrine-immunological cross-talk in Kaposi’s sarcoma.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
P. Cassoni, T. Marrocco, B. Bussolati, E. Allia, L. Munaron, A. Sapino, and G. Bussolati
Oxytocin Induces Proliferation and Migration in Immortalized Human Dermal Microvascular Endothelial Cells and Human Breast Tumor-Derived Endothelial Cells
Mol. Cancer Res., June 1, 2006; 4(6): 351 - 359.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
A. J. Stratigos, D. Malanos, G. Touloumi, A. Antoniou, I. Potouridou, D. Polydorou, A. D. Katsambas, D. Whitby, N. Mueller, J. D. Stratigos, et al.
Association of Clinical Progression in Classic Kaposi's Sarcoma With Reduction of Peripheral B Lymphocytes and Partial Increase in Serum Immune Activation Markers
Arch Dermatol, November 1, 2005; 141(11): 1421 - 1426.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
C Pequeux, B P Keegan, M-T Hagelstein, V Geenen, J-J Legros, and W G North
Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway
Endocr. Relat. Cancer, December 1, 2004; 11(4): 871 - 885.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Pequeux, C. Breton, J.-C. Hendrick, M.-T. Hagelstein, H. Martens, R. Winkler, V. Geenen, and J.-J. Legros
Oxytocin Synthesis and Oxytocin Receptor Expression by Cell Lines of Human Small Cell Carcinoma of the Lung Stimulate Tumor Growth through Autocrine/Paracrine Signaling
Cancer Res., August 15, 2002; 62(16): 4623 - 4629.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.